Back to Screener

Healthcare

Crinetics Pharmaceuticals, Inc.(CRNX)

Live Price

Offline

$34.97

-3.34% today

1Y Change

+17.95%

Window

Jun 25, 2025 โ†’ Jun 18, 2026

Market Cap
$4.27B
Revenue Growth
+640.7%
EPS Growth
-34.1%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 25, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Crinetics Pharmaceuticals, Inc. (CRNX) is a Healthcare stock with a market cap of $4.27B. The stock last traded around $34.97 and up 18.0% across the available one-year price window (Jun 25, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +640.7%, EPS growth of -34.1%, a dividend yield of 0.0%. What stands out right now is revenue +640.7%, EPS -34.1%, free cash flow -67.0% with operating margin -9534.5% and ROIC -48.9%. Valuation already assumes a fairly strong business story at price/sales 787.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CRNX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CRNX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CRNX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CRNX Max Drawdown

-42.21%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CRNX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -1.20
โ€”
โ€”
Est 8511.2B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
-1.29
Est -1.37
+5.8%
6161.0B
Est 4490.0B
+37.2%
Feb 26
โ€”
Nov 6, 25
โœ—
-1.38
Est -1.27
-8.7%
143.0B
Est 4323.3B
-96.7%
Nov 6
โ€”
Aug 7, 25
โœ—
-1.23
Est -1.13
-8.8%
1031.0B
Est 394.0B
+161.7%
Aug 7
โ€”
May 8, 25
โœ—
-1.04
Est -0.99
-5.0%
361.0B
Est 347.9B
+3.8%
May 8
โ€”
Feb 27, 25
โœ“
-0.88
Est -0.92
+4.3%
โ€”
Est 727.3B
โ€”
Feb 27
โ€”
Nov 12, 24
โœ—
-0.96
Est -0.91
-5.4%
โ€”
Est 218.1B
โ€”
Nov 12
โ€”
Aug 8, 24
โœ—
-0.94
Est -0.86
-9.3%
399.0B
Est 510.0B
-21.8%
Aug 8
โ€”
May 9, 24
โœ—
-0.93
Est -0.84
-10.7%
640.0B
Est 260.0B
+146.2%
May 9
โ€”
Feb 28, 24
โœ—
-0.90
Est -0.89
-1.1%
โ€”
Est 260.0B
โ€”
Feb 28
โ€”
Nov 7, 23
โœ—
-1.01
Est -0.89
-13.5%
346.0B
Est 190.0B
+82.1%
Nov 7
โ€”
Aug 8, 23
โœ—
-0.94
Est -0.85
-10.6%
988.0B
Est 140.0B
+605.7%
Aug 8
โ€”
May 4, 23
โœ—
-0.85
Est -0.82
-3.7%
2679.0B
Est 630.0B
+325.2%
May 4
โ€”
Feb 28, 23
โœ—
-0.84
Est -0.82
-2.4%
709.0B
Est 250.0B
+183.6%
Feb 28
โ€”
Nov 14, 22
โ€”
-0.78
Est -0.78
0.0%
458.0B
Est 250.0B
+83.2%
Nov 14
โ€”
Aug 12, 22
โœ—
-0.81
Est -0.62
-30.6%
439.0B
Est 600.0B
-26.8%
Aug 12
โ€”
May 12, 22
โœ—
-0.73
Est -0.56
-30.4%
3131.0B
Est 5200.0B
-39.8%
May 12
โ€”
Mar 30, 22
โœ—
-0.68
Est -0.57
-19.3%
1078.0B
Est โ€”
โ€”
Mar 30
โ€”
Nov 5, 21
โœ—
-0.73
Est -0.70
-4.3%
โ€”
Est โ€”
โ€”
Nov 5
โ€”
Aug 10, 21
โœ—
-0.70
Est -0.60
-16.7%
โ€”
Est โ€”
โ€”
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener